Logo

Roche and Fluidigm to Co-Market 454's Sequencers, Fluidigm's Multiplexed PCR Arrays

Oct 19, 2010
Premium

Roche's 454 Life Sciences and Fluidigm said this week that they will co-promote their respective amplicon sample-prep and sequencing platforms.

The partnership involves 454's GS FLX and GS Junior sequencers and Fluidigm's Access Array system, which enables users to generate 48 PCR amplicons for 48 samples simultaneously.

The companies said they will offer a "robust and streamlined workflow" that minimizes the number of manual steps required for targeted sequencing applications.

454 President and CEO Chris McLeod said in a statement that the Access Array and GS Junior systems are "extremely complementary," allowing large numbers of samples and amplicons to be analyzed "in an affordable workflow, without the need for complicated liquid handling."

Filed under

Clinical Sequencing
Sequencing
PCR
Fluidigm
Roche
ABRF
Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.